A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
about
Transplant-associated thrombotic microangiopathy: opening Pandora's box.Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy.Treatment of severe, refractory and rapidly evolving thrombotic thrombocytopenic purpura.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Thrombotic Microangiopathy and the Kidney.Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases.Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without RituximabTreatment of Concurrent Thrombotic Thrombocytopenic Purpura and Graves' Disease: A Report on Two Cases
P2860
Q30235311-C897E8D6-6C31-463B-82FC-6A2FE58B8DB2Q33427885-3E2DCB0A-C88B-4B9D-8562-D15D6DC0EE4DQ33432293-2D628103-8D68-426D-80E7-FF662ED64C1FQ33432927-90479587-3F34-4FDA-A8C4-9BE9610D5BA1Q42086661-4E9699A0-6934-4F6E-9C02-733FF4421C02Q50085453-995C70F5-F88C-43B1-8EA1-4D067251D664Q54306708-644A352E-9F06-418D-BB5C-5EADC96D30DFQ58708963-59DECC12-0400-4F6E-8F84-32A4AFCA1F5CQ58792863-C60A4F11-04E8-48EB-A542-E3E27A8BEDE9
P2860
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase-II sequential case-ser ...... urpura treated with rituximab.
@ast
A phase-II sequential case-ser ...... urpura treated with rituximab.
@en
type
label
A phase-II sequential case-ser ...... urpura treated with rituximab.
@ast
A phase-II sequential case-ser ...... urpura treated with rituximab.
@en
prefLabel
A phase-II sequential case-ser ...... urpura treated with rituximab.
@ast
A phase-II sequential case-ser ...... urpura treated with rituximab.
@en
P2093
P2860
P356
P1476
A phase-II sequential case-ser ...... urpura treated with rituximab.
@en
P2093
Donald M Arnold
John G Kelton
Kathyrn E Webert
Paul R Yenson
Steven R Foley
William F Clark
members of Canadian Apheresis Group
P2860
P304
P356
10.1111/BJH.13408
P407
P50
P577
2015-04-08T00:00:00Z